Clinical Trials Browser

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Clinical Trials

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

PALANGI3

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Neoadjuvant Tebentafusp for Uveal Melanoma

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

A Phase II Study of BVD-523 in Metastatic Uveal Melanoma

O-Mel-Sora

Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

DIET

Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

Psychoeducation for Uveal Melanoma

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma

Tebentafusp-tebn With LDT in Metastatic UM

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

PLUME

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

ctDNA R0

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

MELCOM

CHOPIN

EARLY TOGETHER

SALOME

Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

TebeMRD

Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma

SILVER

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

NADOM

Adjuvant Quisinostat in High-Risk Uveal Melanoma

IHOPE

Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma

AMUM

SITISVEAL

Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

DeCOG

PROTECT